O

Oncolytics Biotech

ONCY

1.03000
USD
-0.02
(-1.90%)
مغلق
حجم التداول
25,740
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
96,840,071
أصول ذات صلة
C
CLDX
-0.540
(-1.42%)
37.560 USD
F
FATE
-0.46000
(-8.61%)
4.88000 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
الأخبار المقالات

العنوان: Oncolytics Biotech

القطاع: Healthcare
الصناعة: Biotechnology
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.